Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients. 1988

P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
Research and Development Department, CIBA-GEIGY Ltd., Basle, Switzerland.

1. The kinetics of diclofenac (I) and five of its metabolites (II-VI) were investigated in three healthy volunteers and in six patients. Compounds I-VI were measured by capillary column gas chromatography in plasma and urine. 2. After a single 100 mg dose of diclofenac sodium to volunteers, the drug was absorbed rapidly and showed peak plasma levels of 10-12 nmol/g. The maximum concentrations of five metabolites were comparatively low (0.36-2.94 nmol/g). The mono- and dihydroxy metabolites (II-V) had apparent terminal half-lives similar to that of I (1-3 h), but the hydroxymethoxy metabolite (VI) had a half-life of about 80 h. Renal elimination of VI within 96 h was about 1% of dose and that of I-VI was 36% (free plus conjugated). 3. Following daily treatment with 2 x 75 mg of an experimental sustained release formulation to patients for 6-10 months, steady-state trough concentrations of I-V in plasma were low (average values: 0.23-0.57 nmol/g). The mean trough concentration of VI was comparatively higher at 3.69 +/- 0.91 nmol/g presumably reflecting its accumulation. Despite this it is unlikely to contribute to the drug's therapeutic activity, since it has been shown in laboratory tests to be devoid of anti-inflammatory activity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004008 Diclofenac A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. Diclophenac,Dichlofenal,Diclofenac Potassium,Diclofenac Sodium,Diclonate P,Dicrofenac,Feloran,GP-45,840,Novapirina,Orthofen,Orthophen,Ortofen,SR-38,Sodium Diclofenac,Voltaren,Voltarol,Diclofenac, Sodium,GP 45,840,GP45,840,SR 38,SR38
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
December 1987, Journal of clinical pharmacology,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
December 1998, Journal of clinical pharmacology,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
December 1998, Journal of clinical pharmacology,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
September 1989, Therapeutic drug monitoring,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
January 2003, Clinical pharmacokinetics,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
January 1991, Chemotherapy,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
August 2004, International journal of clinical pharmacology and therapeutics,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
November 2012, International journal of clinical pharmacology and therapeutics,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
January 2007, Chinese medical journal,
P H Degen, and W Dieterle, and W Schneider, and W Theobald, and U Sinterhauf
January 1983, European journal of clinical pharmacology,
Copied contents to your clipboard!